Osborn Williams & Donohoe’s Sanofi SNY Stock Holding History

Osborn Williams & Donohoe’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,750	Closed	-$162K	–	608
2019 Q1	$162K	Buy	+3,750	New	+$161K	0.02%	357
2016 Q1	–	Sell	-4,920	Closed	-$210K	–	230
2015 Q4	$210K	Hold	4,920	–	–	0.04%	196
2015 Q3	$234K	Sell	4,920 -150	-3%	-$7.64K	0.05%	187
2015 Q2	$271K	Hold	5,070	–	–	0.05%	184
2015 Q1	$251K	Hold	5,070	–	–	0.05%	200
2014 Q4	$231K	Hold	5,070	–	–	0.05%	206
2014 Q3	$286K	Hold	5,070	–	–	0.06%	182
2014 Q2	$262K	Sell	5,070 -100	-2%	-$5.31K	0.05%	193
2014 Q1	$270K	Buy	5,170 +100	+2%	+$5.06K	0.06%	187
2013 Q4	$272K	Sell	5,070 -300	-6%	-$15.5K	0.06%	186
2013 Q3	$272K	Hold	5,370	–	–	0.07%	189
2013 Q2	$277K	Buy	+5,370	New	+$286K	0.07%	181

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Osborn Williams & Donohoe's SNY Position: Q2 2019 in Review

Osborn Williams & Donohoe sold out of Sanofi (SNY) in Q2 2019, closing a stake of 3,750 shares — an estimated $162K sold.

Osborn Williams & Donohoe first reported a position in SNY in Q2 2013 and held it in 12 quarters. The position peaked at $286K in Q3 2014. 482 funds tracked by Wall St. Rank hold SNY as of Q2 2019.

Osborn Williams & Donohoe reported no remaining Sanofi position as of Q2 2019 after selling out during the quarter.
Osborn Williams & Donohoe sold 3,750 Sanofi shares in Q2 2019, an estimated $162K.
Osborn Williams & Donohoe first reported a position in Sanofi in Q2 2013 and held it in 12 quarters.
Osborn Williams & Donohoe's Sanofi position peaked at $286K in Q3 2014.
482 funds tracked by Wall St. Rank held Sanofi as of Q2 2019.

Based on Osborn Williams & Donohoe's 13F filing for Q2 2019, filed 26 Jul 2019.